Publications
Résultats 241 à 250 sur 563 Publications
| Titre | Auteurs | Année | Revue |
|---|---|---|---|
| CCCDTD5: Reducing the risk of later‐life dementia. Evidence informing the Fifth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia | Rockwood K*, Andrews MK*, Aubertin-Leheudre M, Belleville S*, Bherer L*, Bowles SK, Kehler DS, Lim A*, Middleton L*, Philips N*, Wallace LK | 2020 | Alzheimer's & Dementia: Translational Research & Clinical Interventions |
| CCCDTD5 recommendations on early non cognitive markers of dementia: A Canadian consensus | Montero-Odasso M*, Pieruccini-Faria F**, Ismail Z*, Li K*, Lim A*, Philips N*, Kamkar N, Sarquis-Adamson Y*, Speechley M*, Wallace L, Camicioli R* | 2020 | Alzheimer's & Dementia: Translational Research & Clinical Interventions |
| CCCDTD5: Individual and community‐based psychosocial and other non‐pharmacological interventions to support persons living with dementia and their caregivers | Vedel I*, Sheets D, McAiney C*, Clare L*, Brodaty H, Mann J, Anderson N*, Liu-Ambrose T*, Rojas-Rozo L, Loftus L, Gauthier S*, Sivananthan S | 2020 | Alzheimer's & Dementia: Translational Research & Clinical Interventions |
| A new role for matrix metalloproteinase-3 in the NGF metabolic pathway: Proteolysis of mature NGF and sex-specific differences in the continuum of Alzheimer’s pathology | Pentz R, Iulita MF, Mikutra-Cencora M, Ducatenzeiler A, Benett DA, Cuello AC* | 2020 | Neurobiology of Disease |
| Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer’s Disease Neuroimaging Initiative | Karikari TK, Benedet AL, Ashton NJ, Lantero Rodriguez J, Snellman A, Suárez-Calvet M, Saha-Chaudhuri P, Lussier F, Kvartsberg H, Moscoso Rial A, Pascoal TA, Andreasson U, Scholl M, Weiner H, Rosa-Neto P*, Trojanowski JQ, Shaw LM, Blennow K, Zetterberg H, for the Alzheimer's Disease Neuroimaging Initiative | 2020 | Molecular Psychiatry |
| Dual-task gait speed assessments with an electronic walkway and a stopwatch in older adults. A reliability study | Montero-Odasso M*, Sarquis-Adamson Y, Kamkar N, Pieruccini-Faria F, Bray N, Cullen S, Mahon J, Titus J, Camicioli R*, Borrie MJ*, Bherer L*, Speechley M* | 2020 | Experimental Gerontology |
| Topographical distribution of amyloid-β, tau and atrophy in behavioral / dysexecutive AD patients | Therriault J, Pascoal TA, Savard M, Benedet AL, Chamoun M, Tissot C, Lussier F, Kang MS, Thomas E, Terada T, Rej S, Massarweh G, Nasreddine Z, Vitali P, Soucy JP, Saha-Chaudhuri P, Gauthier S*, Rosa-Neto P* | 2020 | Neurology |
| Trial of remote ischaemic preconditioning in vascular cognitive impairment (TRICVCI): protocol | Ganesh A, Barber P, Black SE,* Corbett D, Field TS, Frayne R, Hachinski V*, Ismail Z*, Mai LM, McCreary CR, Sahlas D, Sharma M, Schwartz RH, Smith EE* | 2020 | BMJ Open |
| The temporal relationship between white matter hyperintensities, neurodegeneration, amyloid beta, and cognition | Dadar M, Camicioli R, Duchesne S, Collins DL, for the ADNI | 2020 | Diagnosis, Assessment & Disease Monitoring |
| CCCDTD5 recommendations on early non cognitive markers of dementia: A Canadian consensus | Montero-Odasso M*, Pieruccini-Faria F**, Ismail Z*, Li, K*, Lim A*, Philips N*, Kamkar N, Sarquis-Adamson Y, Speechley M*, Theou O*, Verghese J, Wallace L, Camicioli R* | 2020 | Translational Research & Clinical Interventions |
Résultats 241 à 250 sur 563 Publications